Bradley Hospital
Riverside, Rhode Island, 02915, United States
NCT Number: NCT07379853
The project involves the development of an eLearning platform to train therapists in the delivery of exposure therapy for clients with anxiety disorders and OCD. Following initial development, clinician end users will complete rounds of iterative feedback to inform final development, at which point, therapists will be recruited to complete the entire training program in an open trial.
Interested in participating?
Request Info21 year–99 year
All sexes
Interventional
Not applicable
Riverside, Rhode Island, 02915, United States
Despite the existence of numerous well-established evidence-based practices (EBPs) for mental disorders, it has been difficult to disseminate these practices in community settings. Exposure therapy for anxiety disorders represents one of the most glaring examples of this research-to- practice gap. Many practicing therapists have never had the opportunity to receive training in exposure therapy and cite this as a primary barrier to its delivery. To address this gap, investigators need to rethink the way in which they train providers. Recent advances in e-learning offer an exciting opportunity to automate both the didactic and interactive components of these evidence-based training modules-an approach that has potential to vastly improve scalability, thus addressing a primary barrier to accessing the most potent treatment available for anxiety. In this project, the team will develop and initially test an automated eLearning approach for therapists learning exposure therapy. The investigators will leverage evidence-based training content and strategies from their prior work, as well as recent advances in eLearning (e.g., adaptive eLearning). The proposed Phase I STTR study will take place in three stages. Stage one (Development) is a nine-month development period during which PARC Innovations will build an alpha version of the training program in accordance with specifications from the research team and early input from a Multi-perspective Advisory Panel (MAP). The MAP (N=8) will consist of professionals with expertise in commercialization, education & e-learning, and/or technology. In Stage two (End- User Feedback and Optimization), a group of clinician end-users (N = 8) will interact with the platform and provide quantitative and qualitative feedback that will be synthesized by the research team into action items for further development. In stage three (Training Trial), therapists (N=40) will complete 8 hours of e-learning training (self-paced) over three weeks. Usability and training outcomes (e.g., therapist knowledge, self-efficacy) from this pilot trial will support a Phase II STTR project aimed at building out and broadly disseminating this eLearning approach.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Therapist training in Exposure Therapy delivery using an eLearning platform
Time frame: Immediately before initiating the training program and immediately after completing the 10-hour training intervention.
The TBES is a well-validated, 21-item likert measure of therapist reservations about exposure therapy delivery. Total scores range from 0-84 with higher scores representing more reservations about using exposure therapy with clients.
Time frame: Immediately before starting the training program and immediately after completing the 10-hour training intervention
The SUS is a well-validated measure of usability and acceptability of new innovations. This measure is especially common in the evaluation of new software systems. The measure consists of a 10-item measure on a 5-point likert scale. The scale is converted to a 0-100 score with higher scores indicating higher levels of perceived usability.
Bradley Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07216638
ANXIETY DISORDERS (or Anxiety and Phobic Neuroses), Anxiety Disorders
Indianapolis, Indiana, United States
View Trial DetailsNCT07682064
ANXIETY DISORDERS (or Anxiety and Phobic Neuroses), Anxiety Disorders
Logroño, La Rioja, Spain
View Trial DetailsNCT07346911
ANXIETY DISORDERS (or Anxiety and Phobic Neuroses), Anxiety Disorders
Oslo, Norway
View Trial DetailsNCT06661460
ANXIETY DISORDERS (or Anxiety and Phobic Neuroses), Agoraphobia
Kalmar, Region Kalmar Län, Sweden
View Trial Details